Skip to search formSkip to main contentSkip to account menu

Revaprazan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract The purpose of this research was to develop a novel revaprazan-loaded surface-modified solid dispersion (SMSD) with… 
2018
2018
Abstract To develop a novel revaprazan-loaded gelatine microsphere with enhanced solubility and oral bioavailability, numerous… 
Review
2018
Review
2018
  • K. Sugano
  • Therapeutic advances in gastroenterology
  • 2018
  • Corpus ID: 2468059
Potassium-competitive acid blocker (P-CAB) is a class of drug that competitively blocks the potassium-binding site of H+, K… 
2015
2015
Background/Aims Proton pump inhibitors (PPIs) act by irreversibly binding to the H+-K+-ATPase of the proton pump in parietal… 
2012
2012
Chronic gastric inflammation developing after Helicobacter pylori (H. pylori) infection is responsible for either dyspeptic… 
2010
2010
Background and Aim:  Revaprazan is a novel acid pump antagonist. The aim of this study was to investigate the inhibitory effect… 
2009
2009
Inhibition of H+,K+-ATPase is accepted as the most effective way of controlling gastric acid secretion. However, current acid… 
2007
2007
Background/Aims: This randomized, double-blind, phase III, multicenter trial was carried out to compare the efficacy and safety… 
2005
2005
Background/Aims: To assess the comparative efficacy and safety of revaprazan, a novel acid pump antagonist, versus omeprazole in…